NM_000433.3(NCF2):c.55_63delAAGAAGGAC (p.Lys19_Asp21del) AND Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2
| Significance: | Pathogenic |
|---|---|
| ClinVar: | RCV000002333 |
Variant: NM_000433.3(NCF2):c.55_63delAAGAAGGAC (p.Lys19_Asp21del) |
|
| Type: | Variant |
Allele: NM_000433.3(NCF2):c.55_63delAAGAAGGAC (p.Lys19_Asp21del) 17284 |
|
| Gene: | NCF2 |
| Type: | Deletion |
| Location: |
Chr1: 183559402
- 183559410
- assembly
GRCh37 Chr1: 183590267 - 183590275 - assembly GRCh38 |
| References: | dbSNP:
796065033 OMIM: 608515.0006 |
Condition |
|
| Disease: | Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2 |
Citation |
|
|
In a 16-year-old girl with chronic granulomatous disease (233710), the offspring of unrelated parents who were natives of Mexico, Patino et al. (1999) found compound heterozygosity for a 9-bp deletion (AAGAAGGAC) involving nucleotides 55-63 in exon 2 of the NCF2 gene, predicting elimination of lys19/lys20/asp21 from the NCF2 protein. The maternal allele also contained a C-to-T transition at nucleotide 1183 in exon 14, resulting in an arg395-to-trp mutation (R395W; 608515.0010). The mother was heterozygous for these mutations. The allele from the father had an IVS4DS+1G-A mutation (608515.0005). PMID:10498624 |
|